UHS Q3 FY2026: revenue up 5.3%, EPS down 10.9% as margins thin
UHS grew third-quarter revenue 5.3% to $4.73 billion but earned $5.22 per diluted share, down 10.9% from a year earlier and only about a penny above the $5.2068 consensus. Read the quarter as volume growth fighting margin erosion: adjusted EBITDA margin fell to 13.2% from 14.9%. Start with the one-off items in the scorecard, then the balance sheet, where debt jumped for acquisitions.
1 · Expected vs. Actual
Free preview belowDiluted EPS fell 10.9% to $5.22 from $5.86, though it edged past the $5.2068 consensus. The comparison carries a one-off drag: last year's quarter held roughly $55 million of net favorable pre-tax items versus $21 million this year, and adjusted EPS still slipped to $5.22 from $5.69. A 7.1% smaller diluted share count (59.1 million versus 63.7 million) cushioned the fall.
Revenue of $4.73 billion rose 5.3% from $4.50 billion a year earlier. Growth was volume-led: acute-care same-facility adjusted admissions rose 4.9% while revenue per adjusted admission fell 1.7%, and behavioral same-facility revenue rose 4.0%. Pricing was not the engine, which is why the top line looks better than the profit line.
Log in to read 35 analyses a week for free
Create a free account to read 35 full earnings analyses each week — all five steps: expected vs. actual, guidance tracker, money flow, balance sheet and risks. Members get unlimited access.
Figures on this page come from the company's original SEC filings. The analysis is generated automatically and checked against validation rules, but may still contain errors or omissions. Not investment advice. · Generated 2026-11-07
Answers are based on the earnings release and the analysis above. Free accounts get 3 questions a week; members get 30 a day.